163 related articles for article (PubMed ID: 18780572)
21. What is the role of arsenic in newly diagnosed APL?
Tallman MS
Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
[TBL] [Abstract][Full Text] [Related]
22. The expanding role of arsenic in acute promyelocytic leukemia.
Tallman MS
Semin Hematol; 2008 Jul; 45(3 Suppl 2):S25-9. PubMed ID: 18760708
[TBL] [Abstract][Full Text] [Related]
23. Acute promyelocytic leukemia: morphological aspects.
Castoldi GL; Liso V; Specchia G; Tomasi P
Leukemia; 1994; 8 Suppl 2():S27-32. PubMed ID: 7815833
[TBL] [Abstract][Full Text] [Related]
24. Presentation of acute promyelocytic leukemia as granulocytic sarcoma.
Worch J; Ritter J; Frühwald MC
Pediatr Blood Cancer; 2008 Mar; 50(3):657-60. PubMed ID: 17437290
[TBL] [Abstract][Full Text] [Related]
25. Expression of cell-surface antigens in acute promyelocytic leukaemia.
Paietta E
Best Pract Res Clin Haematol; 2003 Sep; 16(3):369-85. PubMed ID: 12935957
[TBL] [Abstract][Full Text] [Related]
26. Masked t(15;17) APL with the insertion of PML-RARalpha fusion gene in 4q21.
Haraguchi K; Ohno N; Tokunaga M; Tokunaga M; Itoyama T; Gotoh M; Taniwaki M; Tubouchi H
Leuk Res; 2009 Nov; 33(11):1552-5. PubMed ID: 19477514
[TBL] [Abstract][Full Text] [Related]
27. Acute promyelocytic leukemia: morphological aspects.
Castoldi GL; Liso V; Specchia G; Tomasi P
Leukemia; 1994 Sep; 8(9):1441-6. PubMed ID: 8090023
[TBL] [Abstract][Full Text] [Related]
28. The triple-negative (CD34-/HLA-DR-/CD11b-) profile rapidly and specifically identifies an acute promyelocytic leukemia.
Rahman K; Gupta R; Singh MK; Sarkar MK; Gupta A; Nityanand S
Int J Lab Hematol; 2018 Apr; 40(2):144-151. PubMed ID: 28984423
[TBL] [Abstract][Full Text] [Related]
29. Acute promyelocytic leukemia: an unusual cause of fatal secondary postpartum hemorrhage.
Sharma JB; Gupta N; Vimala N; Anand M; Deka D; Mittal S
Arch Gynecol Obstet; 2006 Feb; 273(5):310-1. PubMed ID: 16341866
[TBL] [Abstract][Full Text] [Related]
30. [From chloroma to acute promyelocytic leukemia--a historical perspective].
Schwarz J
Vnitr Lek; 2008; 54(7-8):686-700. PubMed ID: 18780570
[TBL] [Abstract][Full Text] [Related]
31. Correlation between morphological and cytochemical heterogeneity of acute promyelocytic leukemia (APL) and its association with myelodysplasia.
Varma N; Dash S; Sarode R
Indian J Cancer; 1990 Sep; 27(3):165-71. PubMed ID: 2090569
[TBL] [Abstract][Full Text] [Related]
32. A variant acute promyelocytic leukemia with t(11;17) (q23;q12); ZBTB16-RARA showing typical morphology of classical acute promyelocytic leukemia.
Han SB; Lim J; Kim Y; Kim HJ; Han K
Korean J Hematol; 2010 Jun; 45(2):133-5. PubMed ID: 21120193
[TBL] [Abstract][Full Text] [Related]
33. CD2+ acute promyelocytic leukemia is associated with leukocytosis, variant morphology and poorer prognosis.
Kaito K; Katayama T; Masuoka H; Nishiwaki K; Sano K; Sekiguchi N; Hagino T; Kobayashi M
Clin Lab Haematol; 2005 Oct; 27(5):307-11. PubMed ID: 16178910
[TBL] [Abstract][Full Text] [Related]
34. When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).
Cassinat B; de Botton S; Kelaidi C; Ades L; Zassadowski F; Guillemot I; Schlageter MH; Raffoux E; Harousseau JL; Legrand O; Escoffre-Barbe M; Reman O; Gardembas M; Himberlin C; Cahn JY; Guyotat D; Bouscary D; Parry A; Rousselot P; Baruchel A; Dombret H; Chevret S; Fenaux P; Chomienne C
Leuk Res; 2009 Sep; 33(9):1178-82. PubMed ID: 19167754
[TBL] [Abstract][Full Text] [Related]
35. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
[TBL] [Abstract][Full Text] [Related]
36. [Quantification of PML/RAR alpha fusion gene transcripts in patients with acute promyelocytic leukemia by using real-time quantitative PCR].
Lin J; Han LX; Qian J; Wang YL; Qian Z; Yang XF; Sheng XJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):319-21. PubMed ID: 18543226
[TBL] [Abstract][Full Text] [Related]
37. The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia.
Dore AI; Santana-Lemos BA; Coser VM; Santos FL; Dalmazzo LF; Lima AS; Jacomo RH; Elias J; Falcão RP; Pereira WV; Rego EM
J Leukoc Biol; 2007 Nov; 82(5):1340-3. PubMed ID: 17704297
[TBL] [Abstract][Full Text] [Related]
38. Precursor T-lymphoblastic lymphoma as a secondary malignancy in a young patient after successful treatment of acute promyelocytic leukemia.
Szotkowski T; Jarosova M; Faber E; Hubacek J; Hlusi A; Papajik T; Pikalova Z; Kucerova L; Holzerova M; Budikova M; Buriankova E; Plachy R; Potomkova J; Klusova N; Szotkowska R; Indrak K
Onkologie; 2009 Sep; 32(8-9):513-5. PubMed ID: 19745598
[TBL] [Abstract][Full Text] [Related]
39. Evidence of functional interaction between NuMA-RARalpha and RXRalpha in an in vivo model of acute promyelocytic leukemia.
Sukhai MA; Thomas M; Xuan Y; Chan LS; Hamadanizadeh SA; Zhang T; Bharadwaj RR; Schuh AC; Wells RA; Kamel-Reid S
Oncogene; 2008 Aug; 27(34):4666-77. PubMed ID: 18408763
[TBL] [Abstract][Full Text] [Related]
40. [Late and slow diagnosis of acute promyelocytic leukemias--the main cause of early death].
Lemez P; Schwarz J; Jelínek J; Michalová K; Vítek A; Vorlová Z; Penka M; Neuwirt J
Vnitr Lek; 1994 Oct; 40(10):654-9. PubMed ID: 7810084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
